ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2020

Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression.

Fang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.